Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Blackrock (BLK – Research Report) and VEREIT (VER – Research Report).
Blackrock (BLK)
Evercore ISI analyst Glenn Schorr maintained a Buy rating on Blackrock yesterday and set a price target of $956.00. The company’s shares closed last Wednesday at $867.81.
According to TipRanks.com, Schorr is a 4-star analyst with an average return of
Currently, the analyst consensus on Blackrock is a Strong Buy with an average price target of $966.63, a 12.1% upside from current levels. In a report issued on October 8, UBS also maintained a Buy rating on the stock with a $978.00 price target.
See today’s best-performing stocks on TipRanks >>
VEREIT (VER)
In a report released yesterday, Sheila McGrath from Evercore ISI maintained a Hold rating on VEREIT, with a price target of $50.00. The company’s shares closed last Wednesday at $48.10, close to its 52-week high of $50.98.
According to TipRanks.com, McGrath is a 3-star analyst with an average return of
Currently, the analyst consensus on VEREIT is a Hold with an average price target of $50.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BLK:
- Analysts Are Bullish on Top Technology Stocks: Aspen Technology (AZPN), Autodesk (ADSK)
- Leerink Partners Thinks Aligos Therapeutics’ Stock is Going to Recover
- BridgeBio Pharma (BBIO) Gets a Buy Rating from Leerink Partners
- Leerink Partners Maintains a Buy Rating on Sanofi (SNYNF)
- Leerink Partners Believes Gossamer Bio (GOSS) Won’t Stop Here
